Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-12-21Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2022-12-21Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-12-14A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-12-14A Randomized, Double-Blind Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-12-13PLANning Your Every Day Life I Virtual REality : a Study Schizophrenia. Mathurin Serious Game
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-12A Real World Study on the Efficacy and Safety of Agomelatin Combined With Second Generation Antipsychotics in the Treatment of Negative Symptoms in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-12-05Gamma-Amino Butyric Acid (GABA) Deficits and Vulnerability to Cannabinoid-Induced Psychosis
-
CLINICAL_TRIALS study record update · 2022-12-05An Open-label Study to Determine the Pharmacokinetics, Safety and Tolerability of Single Ascending Doses of a Subcutaneous Injection of Lumateperone Long-Acting Injectable (LAI) Formulation in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-29Real-time fMRI Feedback as a Tool to Mitigate Auditory Hallucinations in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-22Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients
-
CLINICAL_TRIALS study record update · 2022-11-21A Randomized, Double-blind, Placebo-controlled Trial Investigating the Effects of Levetiracetam in Early Psychosis
-
CLINICAL_TRIALS study record update · 2022-11-21The Effect and Safety of Accelerated Continuous Theta-burst Stimulation on Metabolic Dysfunction in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-21Self-control, Appetite and Psychotic Diagnose: a Resting State EEG Cross Section Study
-
CLINICAL_TRIALS study record update · 2022-11-21Virtual Reality Job Interview Training: An Enhancement to Supported Employment in Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2022-11-17The Effect of cTBS on First-episode Drug Naive Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-16Repetitive Transcranial Magnetic Stimulation on Appetite and Cognitive Function in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-15The Impact of Caffeine on Cognition in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-11-10A Pilot, Open-Label, Non-Randomized, Single Ascending Dose, Safety and Pharmacokinetic Trial With Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2022-10-31An Open-Label, Multiple Dose, Safety and Pharmacokinetic Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2022-10-28Evaluation of the Role of Neurodegeneration in Treatment Resistant Schizophrenia With GFAP and S100B
-
CLINICAL_TRIALS study record update · 2022-10-27Prolactin Change and Its Effectors in Chinese Patients With Schizophrenia After Antipsychotics Treatment
-
CLINICAL_TRIALS study record update · 2022-10-26Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine
-
CLINICAL_TRIALS study record update · 2022-10-25The Phosphodiesterase Inhibitor Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-10-25Manualized Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia: An Efficacy Pilot Study.
-
CLINICAL_TRIALS study record update · 2022-10-18A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of LY2140023 Monohydrate in the Acute Treatment of Patients With DSM-IV-TR Schizophrenia